Dyne Therapeutics, Inc.
DYN
44 insider filings · Latest: Jun 26, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Jun 5, 2025 | Jun 5 8:07 PM | Beskrovnaya Oxana | Proposed Sale | 1,093 | $13.35 | $14.6K | — | View → |
| May 16, 2025 | May 16 8:10 PM | Scalzo Richard William | Proposed Sale | 2,479 | $11.82 | $29.3K | — | View → |
| May 16, 2025 | May 16 8:09 PM | Beskrovnaya Oxana | Proposed Sale | 2,589 | $11.82 | $30.6K | — | View → |
| Mar 11, 2025 | Mar 11 8:09 PM | Beskrovnaya Oxana | Proposed Sale | 2,153 | $11.38 | $24.5K | — | View → |
| Mar 11, 2025 | Mar 11 8:08 PM | Scalzo Richard William | Proposed Sale | 1,343 | $11.38 | $15.3K | — | View → |
| Mar 5, 2025 | Mar 5 9:10 PM | Kerr Douglas | Proposed Sale | 1,343 | $11.89 | $16.0K | — | View → |
| Mar 5, 2025 | Mar 5 9:09 PM | Cox John | Proposed Sale | 4,067 | $11.89 | $48.4K | — | View → |
| Mar 5, 2025 | Mar 5 9:08 PM | Beskrovnaya Oxana | Proposed Sale | 1,094 | $11.89 | $13.0K | — | View → |
| Mar 5, 2025 | Mar 5 9:07 PM | Scalzo Richard William | Proposed Sale | 915 | $11.89 | $10.9K | — | View → |
| Feb 18, 2025 | Feb 18 9:15 PM | Scalzo Richard William | Proposed Sale | 2,488 | $13.91 | $34.6K | — | View → |
| Feb 18, 2025 | Feb 18 9:14 PM | Beskrovnaya Oxana | Proposed Sale | 2,598 | $13.91 | $36.1K | — | View → |
| Dec 11, 2024 | Dec 11 9:20 PM | HIGH SUSANNA GATTI | Proposed Sale | 5,270 | $28.33 | $149.3K | — | View → |
| Dec 11, 2024 | Dec 11 9:19 PM | Beskrovnaya Oxana | Proposed Sale | 2,334 | $28.33 | $66.1K | — | View → |
| Dec 11, 2024 | Dec 11 9:18 PM | Scalzo Richard William | Proposed Sale | 1,455 | $28.33 | $41.2K | — | View → |
| Nov 25, 2024 | Nov 25 9:11 PM | McNeill Jonathan | Proposed Sale | 19,987 | $29.69 | $593.4K | — | View → |
| Nov 22, 2024 | Nov 22 9:06 PM | Forbion Capital Fund IV Cooperatief U.A. | Proposed Sale | 62,301 | $30.00 | $1.9M | — | View → |
| Nov 18, 2024 | Nov 18 9:40 PM | Incerti Carlo | Proposed Sale | 16,500 | $28.00 | $462.0K | — | View → |
| Nov 18, 2024 | Nov 18 9:13 PM | Farwell Wildon | Proposed Sale | 2,515 | $28.39 | $71.4K | — | View → |
| Nov 18, 2024 | Nov 18 9:10 PM | Scalzo Richard William | Proposed Sale | 2,735 | $28.39 | $77.6K | — | View → |
| Nov 18, 2024 | Nov 18 9:06 PM | Beskrovnaya Oxana | Proposed Sale | 2,856 | $28.39 | $81.1K | — | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Jun 22, 2026 | Jun 23 8:07 PM | Barry E GreeneDirector | Grant/Award | 57,463 | $20.87 | 57,463(D) | View → |
| Jun 5, 2026 | Jun 9 9:15 PM | Edward HurwitzDirector | Grant/Award | 35,152 | $17.04 | 35,152(D) | View → |
| Jun 5, 2026 | Jun 9 9:13 PM | David Charles LubnerDirector | Grant/Award | 35,152 | $17.04 | 35,152(D) | View → |
| Jun 5, 2026 | Jun 9 9:13 PM | Jason P RhodesDirector | Grant/Award | 35,152 | $17.04 | 35,152(D) | View → |
| Jun 5, 2026 | Jun 9 9:12 PM | Dirk KerstenDirector | Grant/Award | 35,152 | $17.04 | 35,152(D) | View → |
| Jun 5, 2026 | Jun 9 9:12 PM | Carlo IncertiDirector | Grant/Award | 35,152 | $17.04 | 35,152(D) | View → |
| Jun 5, 2026 | Jun 9 9:09 PM | Catherine Stehman-BreenDirector | Grant/Award | 35,152 | $17.04 | 35,152(D) | View → |
| Jun 5, 2026 | Jun 9 9:06 PM | Brian S PosnerDirector | Grant/Award | 35,152 | $17.04 | 35,152(D) | View → |
| Feb 12, 2026 | Feb 17 10:11 PM | John CoxDirector, CEO & President | Grant/Award | 285,000 | $16.00 | 285,000(D) | View → |
| Feb 12, 2026 | Feb 17 10:10 PM | Douglas KerrChief Medical Officer | Grant/Award | 130,000 | $16.00 | 130,000(D) | View → |
| Feb 12, 2026 | Feb 17 10:09 PM | Johanna Friedl-NadererChief Commercial Officer | Grant/Award | 90,000 | $16.00 | 90,000(D) | View → |
| Feb 12, 2026 | Feb 17 10:08 PM | Erick LuceraChief Financial Officer | Grant/Award | 105,000 | $16.00 | 105,000(D) | View → |